Perrigo Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE)
DUBLIN (STL.News) Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it is taking steps to voluntarily delist the Company’s ordinary shares from trading on the Tel Aviv Stock Exchange (TASE). Perrigo is delisting its shares from the TASE after divesting its Israeli-based operations earlier this year. As such, Perrigo has requested that the TASE immediately initiate the process to delist the Company’s ordinary shares.
Under Israeli law, the delisting of Perrigo’s ordinary shares from the TASE is expected to become effective three months after the date of the Company’s request to the TASE to delist the Company’s ordinary shares, which occurred on November 22, 2021. Perrigo’s ordinary shares will continue to be listed on the New York Stock Exchange (NYSE), and all of its ordinary shares now traded on the TASE are expected to be transferred to the NYSE where they can continue to be traded.
Perrigo CEO and President Murray S. Kessler commented, “Perrigo has undergone a significant transformation over the past three years. Part of this transformation included the divestiture of our Israeli-based assets earlier this year and we believe now is the appropriate time to delist.”
Perrigo Company plc (NYSE; TASE: PRGO) is a leading provider of Quality, Affordable Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Led by its consumer self-care strategy, Perrigo is the largest store brand OTC player in the U.S. in the categories in which it competes through more than 9,000 SKUs under customer ‘own brand’ labels. Additionally, Perrigo is a Top 10 OTC company by revenue in Europe, where it markets more than 200 branded OTC products throughout 28 countries.